Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Clin Dermatol. 2009 Nov-Dec;27(6):588-93. doi: 10.1016/j.clindermatol.2008.09.016.

    What sentinel node biopsy in patients with melanoma (or patients whose doctors worry that they could have melanoma) might and might not do.

    Source

    Department of Pathology, University of California at San Francisco School of Medicine, 1701 Divisadero Street, Suite 350, San Francisco, CA 94115, USA. philip.leboit@ucsf.edu

    Abstract

    The sentinel lymph node biopsy has taught us important lessons about the behavior of melanoma and, perhaps, of melanocytic nevi. It is of proven prognostic importance in patients whose diagnosis of melanoma is clear-cut. Sentinel lymph node biopsy is an imperfect prognostic tool, however, and although the morbidity of the procedure is low, completion lymphadenectomy has a high morbidity rate and unproven benefit. In the setting of a borderline lesion, small nodal deposits must be interpreted with caution.

    PMID:
    19880045
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk